Clinical Trials
3 trialsNCT03368729 2026-01-23
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
University of Alabama at Birmingham
Phase 1/2 Active not recruiting
NCT02657889 2022-12-01
TOPACIO
Tesaro, Inc.
Phase 1/2 Completed
NCT04655183 2021-06-30
Study of M4344 in Combination With Niraparib
EMD Serono
Phase 1/2 Withdrawn